RxDoctor Payments Data

Somto Nwaedozie, MD

Advanced Heart Failure and Transplant Cardiology · Madison, WINPI 1487216560

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $13,571 of the $16,463 with a category attached, or 82.4%. Philips North America LLC accounts for 80.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $14,995 and has fallen 95.2% since, to $713 in 2025.

$16,463in general payments, 2019–2025

Across 54 payments — averaging $304.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$13K
  • Abbott$1K
  • Boston Scientific$627
  • Actelion Pharmaceuticals US, Inc.$319
  • Amgen$271
  • Endotronix, Inc.$223
  • plus $482 from 6 others

What the payments were for

  • Grants$6274%
  • Travel & lodging$13,57182%
  • Food & beverage$2,07513%
  • Education$1891%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few advanced heart failure and transplant cardiology providers in Wisconsinto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,242
Medicare patients
11
Services billed
11

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$29,419
Ezetimibe11$428
Metoprolol Succinate23$391
Isosorbide Mononitrate ErIsosorbide Mononitrate15$333
ClopidogrelClopidogrel Bisulfate11$197
Losartan Potassium16$129
Atorvastatin Calcium25$128
Furosemide14$89

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →